FGF19 and Insulin resistance: Levels of FGF-19, a classical surrogate of intestinal BA action, are lower despite higher serum bile acid levels in insulin resistance (155, 156), although the effect of improved insulin resistance on these parameters appears to depend on the treatment modality (151, 157, 158, 159, 160, 161).